Page last updated: 2024-10-25

deferoxamine and Ethmoid Sinusitis

deferoxamine has been researched along with Ethmoid Sinusitis in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Ethmoid Sinusitis: Inflammation of the NASAL MUCOSA in the ETHMOID SINUS. It may present itself as an acute (infectious) or chronic (allergic) condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vandevelde, L1
Bondewel, C1
Dubois, M1
De Vuyst, M1

Other Studies

1 other study available for deferoxamine and Ethmoid Sinusitis

ArticleYear
Mucorales and deferoxamine: from saprophytic to pathogenic state.
    Acta oto-rhino-laryngologica Belgica, 1990, Volume: 44, Issue:4

    Topics: Deferoxamine; Ethmoid Sinusitis; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Mu

1990